Publication

 

Medalie JH, Kahn HA, Neufeld HN, Ross E, Goldbourt U. FIVE-YEAR myocardial infarction incidence – II. Association of single variables to age and birthplace. J Chron Dis 1973;26:329-349.
Goldbourt U, Neufeld HN.  Genetic aspects of arteriosclerosis. Arteriosclerosis 1986;6:357-377.
The Israeli SPRINT Study Group. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT).  A randomized intervention trial of nifedipine in patients with acute myocardial infarction.           Eur Heart J 1988;9:354-364.
Zion MM, Balkin J, Rosenmann D, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S, for the SPRINT Study Group.  Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis experience in 5,841 patients in the SPRINT Registry. Chest 1990;98:1331-1335.
Behar S, Goldbourt U, Reicher-Reiss H, Kaplinsky E, and the Principal Investigators of the SPRINT Study. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Am J Cardiol 1990;66:1208-1211.
Goldbourt U, Yaari S. Cholesterol and coronary heart disease mortality. Arteriosclerosis 1990;10:512-519.
Behar S, Tanne D, Abinader E, Agmon J, Barzilai J, Friedman Y, Kaplinsky E, Kauli N, Kishon Y, Palant A. Peled B, Reisin L, Schlesinger Z, Zahavi I, Zion M, Goldbourt U, the SPRINT Study Group. Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance, and short- and long-term mortality rates. Am J Med 1991;91:45-50.
Behar S, Reicher-Reiss H, Goldbourt U, Kaplinsky E, and the . Circadian variation in pain onset in unstable angina pectoris. Am J Cardiol 1991;67:91-93.Principal Investigators of SPRINT, Israel
Greenland P, Reicher-Reiss H, Goldbourt U, Behar S, and the Israeli SPRINT Investigators. In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Circulation 1991;83:484-491.
Behar S, Hod H, Barbash G, Kaplinsky E. Incidence  of and reasons for excluding patients with acute myocardial infarction from thrombolytic therapy. Isr J Med Sci 1991;27:121-123.
Behar S, Abinader E, Caspi A, David D, Flich M, Friedman Y, Hod H, Kaplinsky E, Kishon Y, Kristal N, Laniado S, Markiewicz V, Marmor A, Palant A, Pelled B, Reisin L, Rosenfeld T, Rogun N, Sherf L, Rabinowitz B, Schlesinger Z, Sclarovsky S, Zahavi I, Zion M, Goldbourt U. Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel. Am J Cardiol 1991;68:1291-1294.
Goldbourt U, Rosenthal T, Rubinstein A. Trends in weight and blood pressure in Ethiopian immigrants during their first few years in Israel: Epidemiological observations and implications for the future. Isr J Med Sci 1991;27:260-263.
Behar S, Kaplinsky E, Zion M, Reicher-Reiss H, Feinberg M, Palant A, Peled B, Schlesinger Z, Abinader E, Friedman Y, Barzilai J, Kishon Y, Reisin L, Kauli N, Zahavi I, Agmon J, Goldbourt U for the SPRINT Study Group.  Frequency and prognostic significance of atrial arrhythmias in the late phase of acute myocardial infarction. J Ambulatory Monitor 1992;5:273-283.

 

 

 

Medalie JH, Stange KC, Zyzanski SJ, Goldbourt U. The importance of biopsychosocial factors in the development of duodenal ulcer in a cohort of middle-aged men. Am J Epidemiol 1992;136:1280-1287.
The Bezafibrate Infarction Prevention (BIP) Study Group, Israel. Lipids and lipoproteins in symptomatic coronary heart disease. Circulation 1992;86:839-848.
Behar S, Tanne D, Zion M, Reicher-Reiss H, Kaplinsky E, Caspi A, Palant A, Goldbourt U, for the SPRINT Study Group. Incidence and prognostic significance of chronic atrial fibrillation among 5,839 consecutive patients with acute myocardial infarction. Am J Cardiol 1992;70:816-818.
Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H, and the SPRINT Study Group. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction.  Eur Heart J 1992:13:45-50.
Behar S, Reicher-Reiss H, Abinader E, Agmon J, Barzilai J, Friedman Y, Kaplinsky E, Kauli N, Kishon Y, Palant A, Peled B, Reisin L, Schlesinger Z, Zahavi I, Zion M, Goldbourt U and the SPRINT Study Group. Long-term prognosis after acute myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram. Am J Cardiol 1992;69:985-990.
Behar S, Panosh A, Reicher-Reiss H, Zion M, Schlesinger Z, Goldbourt U, for the SPRINT Study Group. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. Am J Med 1992;93:637-641.
Eldar M, Sievner Z, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S, for the SPRINT Study Group. Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality.  Ann Intern Med 1992;117:31-36.
Behar S, Reicher-Reiss H, Abinader E, Agmon E, Friedman Y, Barzilai J, Kauli N, Kishon Y, Palant A, Peled B, Rabinovich B, Reisin L, Schlesinger Z, Zahavi I, Zion M, Goldbourt U for the SPRINT Study Group. The prognostic significance of angina pectoris preceding the occurrence of a first acute myocardial infarction in 4166 consecutive hospitalized patients.  Am Heart J 1992;123:1481-1486.
Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S, and the SPRINT Study Group. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome.  Am J Med 1993;94:265-273.
Differences in frequency of atherosclerosis and coronary heart disease between populations and ethnic groups. In: Goldbourt U, de Faire U, Berg K (eds.). Genetic Factors in Coronary Heart Disease. Kluwer Academic Publishers. 1993; pp. 3-20.
Behar S, Halabi M, Reicher-Reiss H, Zion M, Kaplinsky E, Mandelzweig L, Goldbourt U, and the SPRINT Study Group. Circadian variation and possible external triggers of onset of myocardial infarction. Am J Med 1993;94:395-400.
Behar S, Zissman E, Zion M, Goldbourt U, Reicher-Reiss H, Shalev Y, Hod H, Kaplinsky E, Caspi A. Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis.  Am Heart J 1993;125:1622-1627.

 

 

 

Goldbourt U. In: Simopoulos AP (ed.). Nutrition and Fitness in Health and Disease.  Coronary heart disease prevention, nutrition, physical exercise and genetics: rationale for aiming at the identification of subgroups at differing genetic risks. World Rev Nutr Diet, Basel, Karger, 1993, vol. 72, pp. 23-37.
Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E, for the SPRINT Study Group. Early administration of nifedipine in suspected acute myocardial infarction. Arch Intern Med 1993;153:345-353.
Goldbourt U, Yaari S, Medalie JH. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees.  Cardiology 1993;82:100-121.
Tanne D, Goldbourt U, Zion M, Reicher-Reiss H, Kaplinsky E, Behar S, and the SPRINT Study Group. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. Stroke 1993;24:1490-1495.
Behar S, Reicher-Reiss H, Shechter M, Rabinowitz B, Kaplinsky E, Abinader E, Agmon J, Friedman Y, Barzilai J, Kauli N, Kishon Y, Palant A, Peled B, Reisin L, Schlesinger Z, Zahavi I, Zion M, Goldbourt U. for the SPRINT Study Group.  Frequency and prognostic significance of secondary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol 1993;71:152-156.
Behar S, Rabinowitz B, Zion M, Reicher-Reiss H, Kaplinsky E, Abinader E, Agmon J, Friedman Y, Kishon Y, Palant A, Peled B, Reisin L, Schlesinger Z, Zahavi I, Goldbourt U for the SPRINT Study Group.  Immediate and long-term prognostic significance of a first anterior versus first inferior wall Q-wave acute myocardial infarction.  Am J Cardiol 1993;72:1366-1370.
Moshkovitz Y, Sclarovsky S, Behar S, Reicher-Reiss H, Kaplinsky E, Goldbourt U and the SPRINT Study Group. Infarct site-related mortality in patients with recurrent myocardial infarction.  Am J Med 1993;94:388-394.
Behar S, Gilat D, Reicher-Reiss H, Kaplinsky E, Zion M, Mandelzweig L, Goldbourt U and the SPRINT Study Group. Myocardial infarction in patients older than 75 years of age: the short- and long-term prognosis in 653 consecutive patients.  Cardiology in the Elderly 1993;1:103-111.
Mandelzweig L, Goldbourt U, Reicher-Reiss H, Behar S, Kaplinsky E, for the SPRINT Study Group. Nifedipine does not improve survival in AMI patients without heart failure.  Cardiovasc Drugs & Ther 1993;7:117-118.
Kornowski R, Goldbourt U, Zion M, Mandelzweig L, Kaplinsky E, Levo Y, Behar S, and the SPRINT Study Group. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. Am J Cardiol 1993;72:883-888.
Behar S, Zissman E, Zion M, Hod H, Goldbourt U, Reicher-Reiss H, Shalev Y, Kaplinsky E, Caspi A, for the SPRINT Study Group.  Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. Am J Cardiol 1993;72:831-834.
Goldbourt U, Behar S, Reicher-Reiss H, Agmon J, Kaplinsky E, Graff E, Kishon Y, Caspi A, Weisbort J, Mandelzweig L, Abinader E, Aharon L, Braun S, David D, Flich M, Friedman Y, Kristal N, Leil N, Mariewicz W, Marmor A, Palant A, Pelled B, Rabinowitz B, Reisin L, Rotuin N, Rosenfeld T, Schlesinger Z, Sclarovsky S, Sherf L, Tzivoni D, Zahavi I, Zion M, Brunner D, for the Bezafibrate Infarction Prevention Study Group. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinical manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial).  Am J Cardiol 1993;71:909-915.
Goldbourt U. In: Goldbourt U, de Faire U, Berg K (eds.).Variation of atherosclerosis and coronary heart disease by age and sex. Genetic Factors in Coronary Heart Disease. Kluwer Academic Publishers, 1994.
Milo C, Reicher-Reiss H, Goldbourt U, Boyko V, Behar S, and the SPRINT Study Group.  Comparison of prognosis of acute myocardial infarction in insulin-treated diabetic women versus men. Am J Cardiol 1994;74:1275-1276.
Goldbourt U for the BIP Study Research Group. The impact of high-density lipoprotein cholesterol on cardiovascular risk: The Bezafibrate Infarction Prevention (BIP) Study.  Proceedings of the 3rd International Symposium on Multiple Risk Factors in Coronary Heart Disease, Florence, Italy, July 1994.
Behar S, Barbash GI, Copel L, Gottlieb S, Goldbourt U, for the SPRINT Study Group and the Israeli Thrombolytic Survey Group. Improved survival of hospitalized patients with acute myocardial infarction from 1981-1983 to 1992 in Israel.  Cor Art Dis 1994;5:1001-1007.
Behar S, Kishon Y, Hod H, Reicher-Reiss H, Rabinowich B, Becker B, Tekess D, Zion M, Kaplinsky E, Goldbourt U, and the SPRINT Study Group. Incidence and prognostic significance of complete heart block complicating anterior wall acute myocardial infarction. Am J Noninvas Cardiol 1994;8:264-269.
Behar S, Gottlieb S, Hod H, Narinsky R, Benari B, Rechavia E, Pauzner H, Rougin N, Kracoff OH, Katz A, Roth A, Goldhammer E, Rudnik L, Faibel HE, Lotan C, Shapira C, Jafari J, Freedberg NA, Daka F, Kanetti M, Weiss T, Barasch E, Klutstein M, Blondheim D, Mahul N, Gelvan A, Barbash G. for the Israeli Thrombolytic Survey Group. Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel. Am J Cardiol 1994;73:438-443.
Behar S, Kaplinsky E, Zion M, Reicher-Reiss H, Leor J, Palant A, Peled B, Schlesinger Z, Abinader E, Friedman Y, Barzilai J, Kishon Y, Reisin L, Zahavi I, Agmon J, Goldbourt U for the SPRINT Study Group. The long-term prognostic significance of high-grade ventricular ectopic activity in survivors of acute myocardial infarction.  Am J Noninvasive Cardiol 1994;8:282-288.
Behar S, Kishon Y, Reicher-Reiss H, Zion M, Kaplinsky E, Abinader E, Agmon J, Friedman Y, Barzilai J, Kauli N, Palant A, Peled B, Reisin L, Schlesinger Z, Zahavi I, Goldbourt U, for the SPRINT Study Group. Prognosis of early versus late ventricular fibrillation complicating acute myocardial infarction. Int J Cardiol 1994;45:191-198.
Behar S, Zion M, Reicher-Reiss H, Kaplinsky E, Goldbourt U, for the SPRINT Study Group. Short-  and long-term prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. Am J Med 1994;96:15-19.
Behar S, Boyko V, Benderly M, Mandelzweig L, Graff E, Reicher-Reiss H, Schneider H, Shotan A, Balkin J, Brunner D, Goldbourt U, for the BIP Study Group. Asymptomatic hyperglycemia in coronary heart disease: frequency and associated lipid and lipoprotein levels in the Bezafibrate Infarction Prevention (BIP) Register. J Cardiovasc Risk 1995;2:241-246.
Hod H, Goldbourt U, Behar S, and the SPRINT Study Group. Bundle branch block in acute Q wave inferior wall myocardial infarction. Eur Heart J 1995;16:471-477.
Kornowski R, Goldbourt U, Boyko V, Behar S, and the SPRINT Study  Group.  Clinical predictors of reinfarction among men and women after a first myocardial infarction. Cardiology 1995;86:163-168.

 

 

 

Leor J, Goldbourt U, Rabinowitz B, Reicher-Reiss H, Boyko V, Kaplinsky E, Behar S, and the SPRINT Study Group. Digoxin and increased mortality among patients recovering from acute myocardial infarction: Importance of digoxin dose. Cardiovasc Drugs Ther 1995;9:723-729.
Leor J, Goldbourt U, Behar S, Boyko V, Reicher-Reiss H, Kaplinsky E, Rabinowitz B, and the SPRINT Study Group. Digoxin and mortality in survivors of acute myocardial infarction: Observatoins in patients at low and intermediate risk. Cardiovasc Drugs Ther 1995;9:609-617.
Feinberg MS, Boyko V, Goldbourt U, Reicher-Reiss H, Mandelzweig L, Zion M, Kaplinsky E, Behar S, SPRINT Study Group. Early risk stratification of patients with a first inferior wall acute myocardial infarction. Int J Cardiol 1995;48:31-38.
Gottlieb S, Goldbourt U, Boyko V, Barbash G, Mandelzweig L, Behar S, for the SPRINT and Thrombolytic Survey Groups. Improvement in the prognosis of patients with acute myocardial infarction in the 1990s compared with the prethrombolytic era: An analysis by age subgroups. Am J Geriat Cardiol 1995;4:17-31.
Leor J, Goldbourt U, Behar S. Is it safe to prescribe digoxin after acute myocardial infarction? Update on continued controversy. Am Heart J 1995;130:1322-1326.
Behar S, Hod H, Benari B, Narinsky R, Pauzner H, Rechavia E, Faibel HE, Katz A, Roth A, Goldhammer E, Freedberg NA, Rougin N, Kracoff O, Shapira C, Jafari J, Lotan C, Daka F, Gottlieb S, Weiss T, Kanetti M, Klutstein M, Rudnik L, Barasch E, Mahul N, Blondheim D, Gelvan A, Barbash G, for the Israeli Thrombolytic Survey Group. On-site catheterization laboratory and prognosis after acute myocardial infarction. Arch Intern Med 1995;155:813-817.
Barasch E, Benderly M, Graff E, Behar S, Reicher-Reiss H, Caspi A, Pelled B, Reisin L, Roguin N, Goldbourt U and the Principal Investigators of the BIP Study Group. Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.  J Clin Epidemiol 1995;48:757-765.
Desegni E, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Zion M, Boyko V, Behar S, and the SPRINT Study Group. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. J Clin Epidemiol 1995;48:1197-1205.
Tanne D, Reicher-Reiss H, Boyko V, Behar S, for the SPRINT Study Group. Stroke risk after anterior wall acute myocardial infarction. Am J Cardiol 1995;76:825-826.
Behar S, Goldbourt U, Barbash G, Modan B. for the SPRINT Study Group and the Israeli Thrombolytic Survey Group. Twenty-five year mortality rate decrease in patients in Israel with a first episode of acute myocardial infarction.  Am Heart J 1995;130:453-458.
Greif H, Kreitler S, Kaplinsky E, Behar S, Scheinowitz M. The effect of short-term exercise on the cognitive orientation for health and adjustment in myocardial infarction patients. Behavioral Medicine 1995;21:75-85.
Braun S, Boyko V, Behar, Reicher-Reiss H, Shotan A, Schlesinger Z, Rosenfeld T, Palant A, Friedensohn A, Laniado S, Goldbourt U, on behalf of the BIP Study Group. Calcium antagonists and mortality in patients with coronary artery disease: A cohort study of 11,575 patients. J Am Coll Cardiol 1996;28:7-11.

 

 

 

Harpaz D, Benderly M, Goldbourt U, Kishon Y, Behar S, for the Israeli BIP Study Group. Effect of Aspirin on mortality in women with symptomatic or silent myocardial ischemia. Am J Cardiol 1996;78:1215-1219.
Benderly M, Graff E, Reicher-Reiss H, Behar S, Brunner D, Goldbourt U, for the BIP Study Group. Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vasc Biol 1996;16:351-356.
Data from the SPRINT Registry. Behar S, Haim H, Hod H, Kornowski R, Reicher-Reiss H, Zion M, Kaplinsky E, Abinader E, Palant A, Kishon Y, Reisin L, Zahavi I, Goldbourt U and the SPRINT Study Group. Long-term prognosis of patients after a Q wave compared with a non-Q wave first acute myocardial infarction. Eur H J 1996;17:1532-1537.
Behar S, Gottlieb S, Hod H, Benari B, Narinsky R, Pauzner H, Rechavia E, Faibel HE, Katz A, Roth A, Goldhammer E, Freedberg NA, Rougin N, Kracoff O, Shapira C, Jafari J, Lotan C, Daka F, Weiss T, Kanetti M, Klutstein M, Rudnik L, Barasch E, Mahul N, Blondheim D, Gelvan A, Barbash G, for the Israeli Thrombolytic Survey Group. The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy. Am J Med 1996;101:184-191.
Gottlieb S, Boyko V, Zahger D, Balkin J, Hod H, Pelled B, Stern S, Behar S for the Israeli Thrombolytic Survey Group. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). JACC 1996;28:1506-1513.
Jonas M, Reicher-Reiss, H, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, Behar S, for the BIP Study Group. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Am J Cardiol 1996;77:1273-1277.
Goldbourt U. Physical activity, long term CHD mortality and longevity – a quarter-century experience of large prospective trials. Medika 1996;8:626-630.
Goldbourt U. Physical activity, long-term CHD mortality and longevity – a review of studies over the last 30 years. In: Simopoulos AP, Pavlou KN (eds): Nutrition and Fitness: Metabolic and Behavioral Aspects in Health and Disease. World Rev Nutr Diet Basel, Karger 1997;82:229-239.
Haim M, Hod H, Reisin L, et al. for the SPRINT Study Group. Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Am J Cardiol 1997;79:717-721.
Gottlieb S, Goldbourt U, Boyko V, Barbash G, Mandelzweig L, Reicher-Reiss H, Stern S, Behar S, for the SPRINT and Thrombolytic Survey Groups. Improved outcome of elderly patients (75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel. Circulation 1997;95:342-350.
Behar S, Graff E, Reicher-Reiss H, Boyko V, Benderly M, Shotan A, Brunner D, for the BIP Study Group. Low total cholesterol is associated with high total mortality in patients with coronary heart disease. Eur Heart J 1997;18:52-59.
Tanne D, Yaari S, Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke 1997;28:83-87.

 

 

 

Behar S, Boyko V, Reicher-Reiss H, Goldbourt U, for the SPRINT Study Group. Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes. Am Heart J 1997;133:290-296.
Reicher-Reiss H, Jonas M, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, Behar S, for the Bezafibrate Infarction Prevention Study Group. Mortality benefits of beta blocking agents for diabetics with coronary artery disease. Cardiol Rev 1997;14:43-46.
Rott D, Behar S, Gottlieb S, Boyko V, Hod H, for the Israeli Thrombolytic Survey Group and the Secondary Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Usefulness of the Killip classification for early risk stratification of patients with acute myocardial infarction in the 1990s compared with those treated in the 1980s. Am J Cardiol 1997;80:859-864.
Goldbourt U. High density lipoprotein cholesterol and cardiovascular disease. ISSFAL Bulletin No. 4, 1997;9-11.
Harpaz D. for The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Ethnic differences in mortality of male and female patients surviving acute myocardial infarction: Long-term follow-up of 5,700 patients. Eur J Epidemiol 1997;13:745-754.
Gottlieb S, Boyko V, Zahger D, et al. for the Israeli Thrombolytic Survey Group. Do smokers really have a better postinfarction prognosis than nonsmokers? Cardiol Rev 1997;14:27-31.
Benderly M, Behar S, Reicher-Reiss H, Boyko V, Goldbourt U, for the SPRINT Study Group. Long-term prognosis of women after myocardial infarction. Am J Epidemiol 1997;146:153-160.
Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997;17:107-113.
Tanne D, Gottlieb S, Hanoch H, Reicher-Reiss H, Boyko V, Behar S, for the SPRINT and Israeli Thrombolytic Survey Groups. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. J Am Coll Cardiol 1997;30:1484-1490.
Goldbourt U. Evaluating the association between drug use and outcome – should the information from observational studies affect therapeutic use? Cardiology 1997;88(Suppl 3):63-67.
Kornowski R, Goldbourt U, Reicher-Reiss H, Reisin L, Haim M, Moshkovitz Y, Caspi A, Behar S, and the SPRINT Study Group. The prognostic significance of infarct-location in patients with recurrent myocardial infarction. Cardiology 1997;88:441-445.
Haim M, Hod H, Kaplinsky E, Reicher-Reiss H, Barzilay J, Boyko V, Goldbourt U, Behar S for the SPRINT Study Group. Frequency and prognostic significance of high-degree atrioventricular block in patients with a first non-Q-wave acute myocardial infarction.  Am J Cardiol 1997;79:674-676.
Marmor, A, Gottlieb S, Hod H, Boyko V, Behar S, for the Israeli Thrombolytic Survey Group. Symptom-oriented nitrate administration and survival after acute myocardial infarction. Cardiology 1998;89:46-51.
Tanne D, Gottlieb S, Caspi A, Hod H, et al. for the Israeli Thrombolytic National Survey Group. Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era. Arch Intern Med 1998;158:601-606.
Braun S,  Boyko V,  Behar S, Reicher-Reiss H, Laniado S, Kaplinsky E, Goldbourt U, on behalf of the BIP Study Research Group. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. J Am Coll Cardiol 1998;31:804-808.
Caspi A, Gottlieb S, Behar S. Delayed percutaneous transluminal coronary angioplasty after acute myocardial infaction. Int J Cardiol 1998;63:199-204.
Behar S. Treatment of angina pectoris with calcium antagonists: Long-term follow-up. Cardiovasc Drugs Therapy 1998;12:119-124.
Haim M, Shotan A, Boyko V, Reicher-Reiss H, Benderly M, Goldbourt U, Behar S, for the BIP Study Group. Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association Classes II and III. Am J Cardiol 1998;81:1455-1460.
Goldbourt U, Brunner D, Behar S, Reicher-Reiss H, for the BIP Study Group. Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) study. Eur Heart J 1998;19(Suppl H):H42-H47.
Jonas M, Goldbourt U, Boyko V, Mandelzweig L, Behar S, Reicher-Reiss H. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction. Cardiovasc Drugs Therapy 1998;12:177-181.
Reicher-Reiss H, Behar S, Boyko V, Mandelzweig L, Kaplinsky E, Goldbourt U. Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Cardiovasc Drugs Therapy 1998;12:171-176.
Haim M, Gottlieb S, Boyko V, Reicher-Reiss H, Hod H, Kaplinsky E, Mandelzweig L, Goldbourt U, Behar S, for the SPRINT and the Israeli Thrombolytic Survey Groups. Prognosis of patients with a first non-Q wave myocardial infarction before and in the reperfusion era. Am Heart J 1998;136:245-251.
Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality. A 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation 1998;98:1365-1371.
Reicher-Reiss H, Jonas M, Mandelzweig L. Beta-blocker therapy in diabetic coronary patients. Diabetes 1998;19:5-7.
Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E, Behar S, for the SPRINT and Thrombolytic Survey Groups. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. Circulation 1998;97:965-970.
Harpaz D, Gottlieb S, Graff E, Boyko V, Kishon Y, Behar S, for the Israeli Bezafibrate Infarction Prevention Study Group. Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Am J Med 1998;105:494-499.
Haim M, Benderley M, Hod H, Reicher-Reiss H, Goldbourt U, Behar, for the SPRINT Study Group. The outcome of patients with a first non-Q wave acute myocardial infarction presenting with ST segment depression, ST segment elevation or no ST deviations on the admission electrocardiogram. Int J Cardiol 1998;67:39-46.

 

 

 

 

 

Reicher-Reiss H, Jonas M, Tanne D, Mandelzweig L, Goldbourt U, Shotan A, Boyko V, Behar for the Bezafibrate Infarction Prevention (BIP) Study Group.  Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients. Am J Cardiol 1998; 82:1532-1535.
Yaari S, Goldbourt U. Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol 1998;148:546-555.
Reicher-Reiss H, Jonas M, Boyko V, Shotan A, Goldbourt U, Behar S. Are coronary patients at higher risk with digoxin therapy? An ongoing controversy. Int J Cardiol 1999;68:137-143.
Grossman E, Messerli FH, Goldbourt U. Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol 1999;83:1090-1093.
Gottlieb S, Boyko V, Harpaz D, Hod H, Cohen M, Mandelzweig L, Khoury , Stern S, Behar S, for the Israeli Thrombolytic Survey Group. Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction. J Am Coll Cardiol 1999;34:70-82.
Leor J, Reicher-Reiss H, Goldbourt U, Boyko V, Gottlieb S, Battler A, Behar S. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1999;33:1920-1925.
Haim M, Benderly M, Brunner D, Behar S, Graff E, Reicher-Reiss H, Goldbourt U, for the BIP Study. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease. The BIP Registry. Circulation 1999;100:475-482.
Tenenbaum A, Fisman EZ, Boyko V, Goldbourt U, Graff E, Shemesh J, Shotan A, Reicher-Reiss H, Behar S, Motro M. Hypertension in diet versus pharmacologically treated diabetics. Mortality over a 5-year follow-up. Hypertension 1999;33:1002-1007.
Tenenbaum A, Fisman EZ, Boyko V, Goldbourt U, Auerbach I, Shemesh J, Shotan A, Reicher-Reiss H, Behar S, Motro M. 109.   Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Am J Cardiol 1999;84:294-298.
Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M. Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology 1999:91:195-202.
The Israeli AMI Survey Group. Characteristics, treatment and prognosis of acute myocardial infarction patients in the ‘90s in Israel. Harefuah 1999;135:573-576.
Harpaz D, Behar S, Gottlieb S, Boyko V, Kishon Y, Eldar M, for the SPRINT Study Group and the Israeli Thrombolytic Survey Group. Complete atrioventricular block complicating acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999;34:1721-1728.

 

 

 

Eldar M, Gottlieb S, Harpaz D, Avidov A, Behar S. Arrhythmias associated with acute myocardial infarction. Cardiac Electrophysiol Rev 1999;3:174-176.
Grossman E, Messerli FH, Goldbourt U. Carcinogenicity of cardiovascular drugs. Current Hypertension Reports 1999;3:212-218.
Feinberg MS, Schwammenthal E, Shlizerman L, Porter A, Hod H, Freimark D, Matezky S, Boyko V, Mandelzweig L, Vered Z, Behar S, Sagie A. Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol 2000;86:903-907.
Behar S. Out-of-hospital death in Israel – Should we blame the Weather?  IMAJ 2000:2:56-57.
Gottlieb S, Goldbourt U, Boyko V, Harpaz D, Mandelzweig L, Khoury Z, Stern S, Behar S, for the SPRINT and Israeli Thrombolytic Survey Groups. Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel: A comparison between 1981-1983 and 1992-1994. Eur Heart J, 2000;21:284-295.
Haim M, Behar S, Boyko V, Hod H, Gottlieb S. The prognosis of a first Q-wave versus non-Q-wave myocardial infarction in the reperfusion era. Am J Med 2000;108:381-386.
Gottlieb S, Harpaz D, Shotan A, Boyko V, Leor J, Cohen M, Mandelzweig L, Mazouz B, Stern S, Behar S for the Israeli Thrombolytic Survey Group. Sex differences in management and outcome after acute myocardial infarction in the 1990s. A prospective observational community-based study. Circulation 2000;102:2484-2490.
Tenenbaum A, Motro M, Fisman EZ, Boyko V, Mandelzweig L, Reicher-Reiss H, Graff E, Brunner D, Behar S. Clinical impact of borderline and undiagnosed diabetes mellitus in patients with coronary artery disease. Am J Cardiol 2000;86:1363-1366.
Shapira I, Pines A, Goldbourt U, Villa Y, Drory Y, for the Israel Study Group on First Acute Myocardial Infarction. Long-term mortality rates reflect progressive prognostic benefits of thrombolysis in patients with first acute myocardial infarction. Cardiology 2000:94:111-117.
The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The Bezafibrate Infarction Prevention (BIP) Study. Circulation 2000;102:21-27.
Tenenbaum A, Motro M, Jonas M, Fisman EZ, Grossman E, Boyko V, Behar S, Reicher-Reiss H. Is diuretic therapy associated with an increased risk of colon cancer? Am J Med 2001;10:143-145.
Reicher-Reiss H, Jonas M, Goldbourt U, Boyko V, Modan B. Selectively increased risk of cancer in men with coronary heart disease. Am J Cardiol 2001;87:459-462.
Behar S. Are right and left bundle branch block similarly associated with increased risk of mortality. Am J Med 2001;110:318-319.
Fisman EZ, Motro M, Tenenbaum A, Boyko V, Mandelzweig L, Behar S. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: A marker for a worse prognosis. Am Heart J 2001;141:485-490.

 

 

 

Solodky A, Behar S, Herz I, Assali A, Porter A, Hod H, Boyko V, Battler A, Birnbaum Y. Comparison of incidence of cardiac rupture among patients with acute myocardial infarction treated by thrombolysis versus percutaneous transluminal coronary angioplasty. Am J Cardiol 2001;87:1105-1108.
Barbash IM, Hasdai D, Behar S, Boyko V, Gottlieb S, Ilia R, Battler A, Leor J for the Israeli Thrombolytic Survey Group. Usefulness of pre-versus postadmission cardiogenic shock during acute myocardial infarction in predicting survival. Am J Cardiol 2001;87:1200-1203.
Barbash IM, Gottlieb S, Goldbourt U, Behar S, Leor J. Aspirin and ACE-inhibitors for wedding or funeral? J Thrombosis & Thrombolysis 2001;11:163-169.
Tenenbaum A, Grossman E, Fisman EZ, Adler Y, Boyko V, Jonas M, Behar S, Motro M, Reicher-Reiss H. Long-term diuretic therapy in patients with coronary disease: increased colon cancer-related mortality over a 5-year follow-up. J Hum Hyperten 2001;15:373-379.
Pudil R, Feinberg MS, Hod H, Boyko V, Mandelzweig L, Behar S. The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. Internat J Cardiol 2001;78:233-239.
Barbash IM, Behar S, Battler A, Hasdai D, Boyko V, Gottlieb S, Leor J, for the Israeli Thrombolytic Survey Group. Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterization facilities. Heart 2001;86:145-149.
Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J 2001;22:1343-1352.
Barbash IM, Battler A, Behar S, Boyko V, Gottlieb S, Hasdai D, Leor J, for the Israeli Thrombolytic Survey Group. Aspirin and percutaneous coronary angioplasty are associated with a decline in mortality from cardiogenic shock. Cardiology 2001;95:119-125.
Tanne D, Benderly M, Goldbourt U, Boyko V, Brunner D, Graff E, ReicherReiss H, Shotan A, Mandelzweig L, Behar S, and the Bezafibrate Infarction Prevention Study Group. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the Bezafibrate Infarction Prevention Study. Am J Med 2001;111:457-463.
Tanne D, Koren-Morag N, Graff E, Goldbourt U, for the BIP Study Group. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry. Circulation 2001;104:2892-2897.
Shotan A, Gottlieb S, Goldbourt U, Boyko V, Reicher-Reiss H, Arad M, Mandelzweig L, Hod H, Kaplinsky E, Behar S, for the Secondary Prevention Reinfarction Israeli Nidefipine Trial (SPRINT) Study Group and the Israeli Thrombolytic Survey Group. Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era – A national study. Am Heart J 2001;141:478-484.
Halkin A, Roth A, Jonas M, Behar S. Sulfonylureas are not associated with increased mortality in diabetes treated with thrombolysis for acute myocardial infarction. J Thromb Thromboylysis 2001;12:177-184.

 

 

 

 

 

Goldenberg I, Matetzky S, Hod H, Behar S, Freimark D. Outcome of patients with electrocardiographic evidence of left ventricular hypertrophy following thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2001;88:1024-1026.
Rott D, Behar S, Leor J, Hod H, Boyko V, Mandelzweig L, Gottlieb S. Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures. Am J Cardiol 2001;88:618-623.
Fisman EZ, Friedensohn A, Kohanovski M, Rotzak R, Schneider H, Behar S, Motro M. Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7 year follow-up. Clin Cardiol 2001;24:151-158.
Blondheim DS, Gottlieb S, Behar S, Marmor AT. Outcome of patients with past acute myocardial infarction ischemia hospitalized in intensive cardiac care units with and without on-site catheterization laboratories. Int J Cardiol 2001;79:41-47.
Rott D, Behar S, Hod H, Feinberg MS, Boyko V, Mandelzweig L, Kaplinsky E, Gottlieb S. Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures. Am Heart J 2001;141:267-276.
Tanne D, Shotan A, Goldbourt U, Haim M, Boyko V, Adler Y, Mandelzweig L, Behar S, for the Bezafibrate Infarction Prevention Study Group. Severity of angina pectoris and risk of ischemic stroke. Stroke 2002;33:245-250.
Freimark D, Matetsky S, Leor J, Boyko V, Barbash IM, Behar S, Hod H. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol 2002;89:381-385.
Goldbourt U, Tanne D. Body height is associated with decreased long-term stroke but not coronary heart disease mortality?  Stroke 2002;33:743-748.
Haim M, Tanne D, Boyko V, et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol 2002;39:1133-1138.
Grossman E, Messerli FH, Boyko V, Goldbourt U. Is there an association between hypertension and cancer mortality? Am J Med 2002;112:479-486.
Koren-Morag N, Tanne D, Graff E, Goldbourt U, for the Bezafibrate Infarction Prevention Registry. Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease. Arch Intern Med 2002;162:993-999.
Tenenbaum A, Motro M, Fisman EZ, Boyko V, Mandelzweig L, Shotan A, Behar S. Does participation in a long-term clinical trial lead to survival gain for patients with coronary artery disease? Am J Med 2002;112:545-548

 

 

 

 

 

Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, Fioretti PM, Simoons ML, Battler A. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin.  Eur Heart J 2002; 23:1190-201.
Froom P, Gofer D, Boyko V, Goldbourt U. Risk for early ischemic event after acute myocardial infarction in working males.  Int J Occupat Med Environ Health 2002;15:43-48.
Tenenbaum A, Motro M, Fisman E, Leor J, Boyko V, Mandelzweig L, Behar S. Status of glucose metabolism in patients with heart failure secondary to coronary artery disease. Am J Cardiol 2002;90:529-532.
Barbash IM, Freimark D, Gottlieb S, Hod H, Hasin Y, Battler A, Crystal E, Matetzky S, Boyko V, Mandelzweig L, Behar S, Leor J, for the Israeli Working Group on Intensive Cardiac Care, Israel Heart Society. Outcome of myocardial infarction in patients treated with aspirin is enhanced by pre-hospital administration. Cardiology 2002;98:141-147.
Rimar D, Crystal E, Battler A, Gottlieb S, Freimark D, Hod H, Boyko V, Mandelzweig L, Behar S, Leor J. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart 2002;88:352-356.
Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Matetsky S, Adler Y, Mekori YA, Behar S. Soluble intercellular adhesion molecule-l and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort. Stroke 2002;33:2182-2186.
Brodov Y, Mandelzweig L, Boyko V, Behar S. Is immigration  associated with an increase in risk factors and mortality among coronary artery disease patients? A cohort study of 13,742 patients. Isr Med Assoc J 2002;4:326-330.
Age-specific relevance of usual blood pressure to vascular mortality; a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet 2002;360:1903-1913.
Lev EI, Battler A, Behar S, Porter A, Haim M, Boyko V, Hasdai D. Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns. Am J Cardiol 2003;91:224-227.
Dankner R, Goldbourt U, Boyko V, Reicher-Reiss H. Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease. Am J Cardiol 2003;91:121-127.
Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela B-A. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 2003;34:632-636.
Zahger D, Behar S, Harpaz D, Leor J, Weiss AT, Gottlieb S, for the Working Group on Intensive Cardiac Care of the Israel Heart Society. Characteristics, management and outcome of patients with prior coronary bypass surgery presenting with acute myocardial infarction. Cardiology 2003;99:105-110.

 

 

 

Tenenbaum A, Motro M, Fisman EZ, Leor J, Freimark D, Boyko V, Mandelzweig L, Adler Y, Sherer Y, Behar S. Ann Functional class in patients with heart failure is associated with the development of diabetes. J Med 2003;114:271-275.
Sprecher DL, Watkins TR, Behar S, Virgil Brown W, Rubins HB, Schaefer EJ. Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease. Am J Cardiol 2003;91:575-580.
Roth A, Malov N, Behar S. Sexual activity cardiological survey on members of the Israel Heart Society.  Int J Clin Pract 2003;57:285-288.
Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Adler Y, Brunner D, Mekori YA, Behar S. Prospective study of chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis 2003;16:166-170.
Hasdai D, Lev EI, Behar S, Boyko V, Danchin N, Vahanian A, Battler A. Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: Lessons from the Euro-Heart Survey of Acute Coronary Syndromes. Eur Heart J 2003;24:623-629.
Hasdai D, Haim M, Behar S, Boyko V, Battler A. Acute coronary syndromes in patients with prior cerebrovascular events: Lessons from the Euro-Heart Survey of Acute Coronary Syndromes. Eur Heart J 2003;146:832-838.
Hasdai D, Behar S, Boyko V, Danchin N, Bassand J-P, Battler A. Cardiac biomarkers and acute coronary syndromes – The Euro Heart Survey of Acute Syndromes Experience. Eur Heart J 2003;24:1189-1194.
Hasdai D, Porter A, Rosengren A, Behar S, Boyko V, Battler A. Effect of gender on outcomes of acute coronary syndromes. Am J Cardiol  2003;91:1466-1469.
Jonas M, Reicher-Reiss H, Boyko V, Behar S, Grossman E. Hospital and one-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension. J Hum Hypertens 2003; 17: 665-670.
Gottlieb S, Leor J, Shotan A, Harpaz D, Boyko V, Rott D, Mandelzweig L, Behar S, for the Working Group on Intensive Caridac Care, Israel Heart Society. Comparison of effectiveness of Angiotensin-Converting Enzyme Inhibitors after acute myocardial infarction in diabetic versus nondiabetic patients. Am J Cardiol 2003; 92:1020-1025.
Goldenberg I, Jonas M, Tenenbaum A, Boyko V, Matetzky S, Shotan A, Behar S, Reicher-Reiss H, for the Bezafibrate Infarction Prevention Group. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med 2003; 163: 2301-2305.
Stern S, Behar S, Gottlieb S. Aging and diseases of the heart. Circulation 2003; 108:e99-e101.
Lipoproteins in acute coronary syndromes – measure, treat or disregard? Henkin Y, Goldbourt U, Gottlieb S. Isr Med Assoc J 2003; 5(6): 428-433.
Gerber Y, Goldbourt U, Segev S, Harats D. Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study. Prev Med 2003; 37(1): 18-22.

 

 

 

Schwammenthal E, Adler Y, Amichai K, Sagie A, Behar S, Hod H, Feinberg MS. Prognostic value of global myocardial performance indices in acute myocardial infarction. Comparison to measures of systolic and diastolic left ventricular function. Chest 2003; 124: 1645-1651.
Tenenbaum A, Motro M, Fisman EZ, Leor J, Boyko V, Mandelzweig L, Behar S. Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis. Cardiology 2003;100:207-215.
Behar S, Battler A, Porath A, Leor J, Grossman E, Hasin Y, et al. for the Israel Heart and Internal Medicine Societies. A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000.  IMAJ 2003;5:249-254.
Froom P, Goldbourt U. Secular decrease in blood pressure and reduction in mortality from cardiovascular disease in Israeli workers. J Hum Hyperten 2004;18:113-118.
Haim M, Boyko V, Goldbourt U, Battler A, Behar S. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease. The Bezafibrate Infarction Prevention Study. Arch Intern Med 2004;164:433-439.
Pereira MA, O’Reilly E, Augustsson K, Fraser GE, Goldbourt U, et al. Dietary fiber and risk of coronary heart disease. A pooled analysis of cohort studies. Arch Intern Med 2004;164:370-376.
Haim M, Tanne D, Battler A, Boyko V, Reshef T, Goldbourt U, Brunner D, Mekori YA, Behar S, for the Bezafibrate Infarction Prevention (BIP) Study Group. Chlamydia pneumoniae and future risk in patients with coronary heart disease. Int J Cardiol 2004;93:25-30.
Haim M, Battler A, Behar S, Fioretti PM, Boyko V, Simoons MI, Hasdai D. Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: Does current treatment comply with guidelines? Am Heart J 2004;147:859-864.
Tenenbaum A, Motro M, Fisman EZ, Schwammenthal E, Adler Y, Goldenberg I, Leor J, Boyko V, Mandelzweig L, Behar S. Peroxisome proliferator-activated receptor ligand Bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation 2004;109:2197-2202.
Rosengren A, Wallentin L, Gitt AK, Behar S, Battler A, Hasdai D.  Sex, age, and clinical presentation of acute coronary syndrome. Eur Heart J 2004;25:663-670.
Hasdai D, Behar S, Boyko V, Battler A. C Treatment modalities of diabetes mellitus and outcomes of acute coronary syndromes. oron Artery Dis 2004;15:129-135.
Solodky A, Assali AR, Behar S, Boyko V, Battler A, Kornowski R.  Anterior wall myocardial infarction in real world: Does reperfusion strategy make any differences? Catheter Cardiovasc Interv 2004;61:79-83.
Tanne D, Koren-Morag N, Goldbourt U. Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks. Stroke 2004;35:2351-2355.
Harpaz D, Behar S, Rozenman Y, Boyko V, Gottlieb S, for the Israeli Working Group on Intensive Cardiac Care, Israel Heart Society. Family history of coronary artery disease and prognosis after first acute myocardial infarction in a national survey. Cardiology 2004;102:140-146.
Stern S, Behar S, Leor J, Harpaz D, Boyko V, Gottlieb S: Israeli Working Group on Intensive Cardiac Care, Israel Heart Society. Presenting symptoms, admission electrocardiogram, management, and prognosis in acute coronary syndromes: differences by age. Am J Geriatr Cardiol 2004;13:188-198.
Beinart R, Boyko V, Schwammenthal E, Kuperstein R, Sagie A, Hod H, Matezky S, Behar S, Eldar M, Feinberg MS. Long-term prognostic significance of left atrial volume in acute myocardial infarction.  J Am Coll Cardiol 2004;44:327-334.
Fisman EZ, Motro M, Tenenbaum A, Leor J, Boyko V, Mandelzweig L, Sherer Y, Adler Y, Behar S. Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up. Eur J Cardiovasc Prev Rehabil 2004;11:135-143.
Tanne D, Goldbourt U, Medalie JH. Perceived family difficulties and prediction of 23-year stroke mortality among middle-aged men. Cerebrovasc Dis 2004;18:277-282.
Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M. Diabetes Mellitus in mid-life and the risk of dementia three decades later. Neurology 2004;63:1902-1907.
Knekt P, Ritz J, Pereira MA, O’Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, et al. Antioxidant, vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004;80:1508-1520.
Arcavi L, Behar S, Caspi A, Reshef N, Boyko V, Knobler H. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: Results from the Bezafibrate Infarction Prevention (BIP) Study. Am Heart J 2004;147:239-245.
Gerber Y, Dankner R, Chetrit A, Novikov I, Goldbourt U. The role of risk factor time trends in the steep decline of CHD mortality between two Israeli cohort studies. Prev Med 2005;41:85-91.
Eilat-Adar S, Goldbourt U, Resnick HE, Howard BV. Intentional weight loss, blood lipids and coronary morbidity and mortality. Current Opinion in Lipidology 2005;16:000-000.
Drory Y, Kravetz S, Koren-Morag N, Goldbourt U, Israel Study Group on First Acute Myocardial Infarction. Resumption and maintenance of employment after a first acute myocardial infarction: Sociodemographic, vocational and medical predictors. Cardiology 2005;103:37-43.
Schnaider Beeri M, Davidson M, Silberman JM, Noy S, Schmeidler J, Goldbourt U. Relationship between body height and dementia. Am J Geriart Psychiatry 2005;13:00-00.
Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Battler A, Mekori YA, Behar S. Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease. Clin Cardiol 2005;28:31-35.
McGee DL and the Diverse Populations Collaborations. Body mass index and mortality: A meta-analysis based on person-level data from twenty-six observational studies. Am Epidemiol 2005;15:87-97.
Tanne D, Medalie JH,  Goldbourt U. Body fat distribution and long-term risk of stroke mortality. Stroke 2005;36:1021-1025.

 

 

 

Tenenbaum A, Motro M, Fisman EZ, Adler Y, Shemesh J, Tanne D, Leor J, Boyko V,  Schwammenthal E, Behar S. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur Heart J 2005;26:2032-2038.
Tenenbaum A, Motro M, Fisman EZ, Tanne D, Boyko V, Behar S. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med 2005;165:1154-1160.
Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack. Stroke 2005;95:1420-1424.
Harats D, Leibovitz E, Maislos M, Wolfovitz E, Chajek-Shaul T, Leitersdorf E, Gavish D, Gerber Y, Goldbourt U, for the HOLEM Study Group. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: Results of the HOLEM Study. IMAJ 2005;7:355-359.
Carasso S, Sandach A, Beinart R, Schwammenthal E, Sagie A, Kuperstein R, Behar S, Feinberg MS, for the Echocardiography Working Group of the Israel Heart Society. Usefulness of four echocardiographic risk assessments in predicting 30-day outcome in acute myocardial infarction. Am J Cardiol 2005;96:25-30.
Moriel M, Behar S, Tzivoni D, Hod, H, Boyko V, Gottlieb S. Management and outcomes of elderly women and men with acute coronary syndromes in 2000 and 2002. Arch Intern Med 2005;165:1521-1526.
Porter A, Iakobishvili Z, Haim M, Behar S, Boyko V, White blood cell count and the incidence of ischemic stroke in coronary heart disease patients. Koren-Morag N, Tanne D, Goldbourt U. Balloon-floating right heart catheter monitoring for acute coronary syndromes complicated by heart failure – discordance between guidelines and reality. Am J Med 2005;118:1004-1009.
Tenenbaum A, Fisman EZ, Adler Y, Motro, M, Boyko V, Behar S. Smoking and development of type 2 diabetes in patients with decreased functional capacity. Int J Cardiol 2005;104:275-281.
Danesh J., et al for the Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality. An individual participant meta-analysis. JAMA 2005;294:1799-1809.
Brodov Y, Sandach A, Behar S. The treatment of acute myocardial infarction among new immigrants in Israel. Harefuah 2005;144:830-833, 912.
Konstantino Y, Iakobishvili Z, Porter A, Sandach A, Zahger D, Hod H, Hammerman H, Gottlieb S, Behar S, Hasdai D. Aspirin, warfarin and a thienopyridine for acute coronary syndromes. Cardiology 2006;105:80-85.
Gerber Y, Tanne D, Medalie JH, Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil 2006;13:193-198.
Zahger D, Hod H, Gottlieb S, Leor J, Hasdai D, Sandach A, Hammerman H, Behar S. Influence of the new definition of acute myocardial infarction on coronary care unit admission, discharge diagnosis, management and outcome in patients with non-ST elevation acute coronary syndromes: A national survey. Int J Cardiol  2006;106:164-169.

 

 

 

 

 

Goldenberg I, Goldbourt U, Boyko V, Behar S, Reicher-Reiss H, for the BIP Study Group. Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Am J Cardiol 2006;97:466-471.
Tanne D, Haim M, Goldbourt U, Boyko V, Reshef T, Adler Y, Benderly M, Mekori YA, Behar S. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart diseaseB.  Int J Cardiol 2006;107:322-326.
Ben-Dor I, Hasdai D, Behar S, Zahger D, Leor J, Hammerman H, Sandach A, Hod H, Gottlieb S and on behalf of the Working Group on Intensive Cardiac Care, Israel Heart Society. Prognostic implications of increased cardiac biomarkers and ST segment depression in non-ST elevation acute coronary syndromes: lessons from the acute coronary syndrome Israeli survey (ACSIS) 2002. Heart 2006;92:547-548.
Weitzman D, Goldbourt U.  The significance of various blood pressure indices for long-term stroke, coronary heart disease, and all-cause mortality in men. The Israeli Ischemic Heart Disease Study. Stroke 2006;37:358-363.
Knobler H, Benderly M, Boyko V, Behar S, Matas Z, Rubinstein A, Raz I, Wainstein J. Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose. Eur J Endocrinol 2006;154:87-92.
Tenenbaum A, Fisman EZ, Boyko V, Benderly M, Tanne D, Haim M, Matas Z, Motro M, Behar S. Attenuation of progression of insulin resistance in patients with coronary artery disease by Bezafibrate. Arch Intern Med 2006;166:737-741.
Tanne D, Benderly M, Goldbourt U, Haim M, Tenenbaum A, Fisman EZ, Matas Z, Adler Y, Zimmlichman R, Behar S. C-Reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006;37:1720-1724.
Fisman EZ, Benderly M, Esper RJ, Behar S, Boyko V, Adler Y, Tanne D, Matas Z, Tenenbaum A. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 2006;98:14-18.
Haim M, Benderly M, Boyko V, Goldenberg I, Tanne D, Battler A, Goldbourt U, Behar S and for the Bezafibrate Infarction Prevention (BIP) Study Group. Decrease in trigylceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudy. Coron Artery Dis 2006;17:455-461.
Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, Shotan A, Behar S, Caspi A, Schwartz R, Tenenbaum A, Leor J. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 2006;166:1613-1619.
Lenderink T, Boersma E, Gitt AK, Zeymer U, Wallentin L, Ven de Werf F, Hasdai D, Behar S, Simoons ML. Patients using statin treatment within 24h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes. Euro H J 2006;27:1799-1804.  

 

 

 

Haim M, Tanne D, Goldbourt U, Doolman R, Boyko V, Brunner D, Sela B-A, Behar S. Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease. Cardiology 2006;107:52-56.
Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, Gitt A, Hasdai D, Hasin Y, Marrugat J, Van de Werf F, Wallentin S, Behar S. The Second Euro Heart Survey on Acute Coronary Syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin. Eur Heart J 2006;27:2285-2293.
Tanne D, Goldbourt U, Koton U, Grossman E, Koren-Morag N, Green MS, Bornstein NM for the National Acute Stroke Israeli Survey Group. A national survey of acute cerebrovascular disease in Israel: Burden, management, outcome and adherence to guidelines. IMAJ 2006;8:3-7.
Tessone A, Gottlieb S, Barbash IM, Garty M, Porath A, Tenenbaum A, Hod H, Boyko V, Mandelzweig L, Behar S, Leor J. Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency. Cardiology 2006;108:193-199.
Iakobishvili Z, Feinberg MS, Danicek V, Behar S, Zahger D, Hod H, Sandach A, Hammerman H, Sagie A, Mager A, Gottlieb S, Hasdai D; Israeli ACSIS 2004 Investigators. Prior heart failure among patients with acute coronary syndromes is associated with a higher incidence of in-hospital heart failure. Acute Card Care 2006;8:143-147.
Yalonetsky S, Gruberg L, Sandach A, Hammerman H, Beyar R, Hod H, Behar S. Rescue percutaneous coronary intervention after failed thrombolysis: results from the Acute Coronary Syndrome Israel Surveys (ACSIS). Acute Card Care 2006;8:83-86.
Hod H, Gottlieb S, Green M, Hammerman H, Zahger D, Hasdai D, Benderly M, Schwartz R, Behar S. Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade. Harefuah 2006;145:326-331 (Hebrew).
Dragu R, Behar S, Sandach A, Boyko V, Kapeliovich M, Rispler S, Hammerman H. Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol 2006;95:1142-1145.
Feinberg MS, Boyko V, Leor J, Kuperstein R, Sagie A, Hod H, Matetzky S, Behar S, Schwammenthal E. Differential value of left atrial systolic and diastolic volumes as independent predictors of congestive heart failure or early death in acute myocardial infarction. Heart 2006;92:397-398.
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, Hasdai D. Euro Heart J 2006;27;789-795.
Xu J, Eilat-Adar S, Loria C, Goldbourt U, Howard BV, Fabsitz RR, Zephier EM, Mattil C, Lee ET. Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr 2006;84:894-902.
Leibovitz E, Gerber Y, Maislos M, Wolfovitz E, Chajek-Shaul T, Leitersdorf E, Goldbourt U, Harats D: HOLEM Study Group. Physicians underdiagnose and undertreat obesity in ischemic heart disease patients: data from the HOLEM Study Group. Isr Med Assoc J 2006;8:553-557.
Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006;67:224-228.
Dankner RS, Chetrit A, Goldbourt U. The metabolic syndrome and glucose tolerance deterioration over 23-year follow-up. Diabetes Care 2006;29(7):1715-1716.
Mandelzweig L, Goldbourt U, Boyko V, Tanne D. Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke. Stroke 2006;37:1248-1253.
Harpaz D, Rosenman Y, Behar S, Boyko V, Mandelzweig L, Gottlieb S; Israeli Working Group on Intensive Cardiac Care, Israel Heart Society. Coronary angiography in the elderly with acute myocardial infarction. Int J Cardiol 2007;116:249-256.
Benderly M, Haim M, Boyko V, Tanne D, Behar S, Matas Z, Zimlichman R, Goldbourt U. C-reactive protein distribution and correlates among men and women with chronic coronary heart disease. Cardiology 2007;107:345-353.
Konstantino Y, Chen E, Hasdai D, Boyko V, Battler A, Behar S, Haim M. Gender differences in mortality after acute myocardial infarction with mild to moderate heart failure. Acute Cardiac Care 2007:9:43-47.
Tenenbaum H, Behar S, Boyko V, Adler Y, Fisman EZ, Tanne D, Lapidot M, Schwammenthal E, Feinberg M, Matas Z, Motro M, Tenenbaum A. Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes. Atherosclerosis 2007:194:265-271.
Gottlieb S, Behar S, Hod H, Zahger D, Leor J, Hasdai D, Hammerman H, Wagner S, Sandach A, Schwartz R, Green MS, Adunsky A, on behalf of the Intensive Cardiac Care Working Group of the Israel Heart Society. Trend in management, hospital and long-term outcomes of elderly patients with acute myocardial infarction. Am J Med 2007;120:90-97.
Hiuge A, Tenenbaum A, Maeda N, Benderly M, Kumada M, Fisman EZ, Tanne D, Matas Z, Hibuse T, Fujita K, Nishizawa H, Adler Y, Motro M, Kihara S, Shimomura I, Behar S, Funahashi T. Effects of peroxisome proliferator-activated receptor ligands, Bezafibrate and Fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol 2007;27:635-641.
Porter A, Iakobishvili Z, Dictiar R, Behar S, Hod H, Gottlieb S, Hammerman H, Zahger D, Hasdai D. The implementation of guidelines and prognosis among patients with acute coronary syndromes is influenced by physician’s perception of antecedent physical and cognitive status. Cardiology 2007;107:422-428.
Feinberg MS, Schwartz R, Tanne D,  Fisman EZ, Hod H, Zahger D,  Schwammenthal E, Eldar M, Behar S, Tenenbaum A. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol 2007;99:667-672.
Tenenbaum A, Adler Y, Boyko V, Tenenbaum H, Fisman EZ, Tanne D, Lapidot M, Schwammenthal E, Feinberg MS, Matas Z, Motro M, Behar S. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting artery disease. Am Heart J 2007;153:559-565.

 

 

 

 

 

Lewis B, Shotan A, Gottlieb S, Behar S, Halon DA, Mittelman M, Caspi A, Garty M, for the HFSIS Investigators. Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: The Israel Nationwide Heart Failure Survey. IMAJ 2007;9:234-238.
Garty M, Shotan A, Gottlieb S, Mittelman M, Porath A, Lewis BS, Grossman E, Behar S, Leor J, Green MS, Zimlichman R, Caspi A,  for the HFSIS Steering Committee and Investigators. The management, early and one year outcome in hospitalized patients with heart failure: A National Heart Failure Survey.  IMAJ 2007;9:227-233.
Goldbourt U, Schnaider-Beeri M, Davidson M. Socioeconomic status in relationship to death of vascular disease and late-life dementia. J Neurol Sci 2007;257:177-181.
Haim M, Benderly M, Tanne D, Matas Z, Boyko V, Fisman EZ, Tenenbaum A, Zimmlichman R, Battler A, Goldbourt U, Behar S. C-reactive  protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease. Am Heart J 2007;154:1095-1101.
Goldenberg I, Benderly M, Goldbourt U, for the BIP Study Group. Secondary prevention with Bezafibrate therapy for the treatment of dyslipidemia. J Am Coll Cariol 2008;51:459-465.
Impact of metabolic syndrome in patients with acute coronary syndrome. In: Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets. Fisman E, Tenenbaum A (eds). Adv Cardiol. Basel, Karger 2008;45:1-13.
Tenenbaum A,  Boyka V, Fisman EZ, Goldenberg I, Adler Y, Feinberg MS, Motro M, Tanne D, Shemesh J, Schwammenthal E, Behar S. Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Cardiovas Diabetol 2008;7:18-22.
Moriel M, Tzivoni D, Behar S, Zahger D, Hod H, Hasdai D,  Sandach A. Gottlieb S. Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes.  Inter J Cardiol 2008;131:97-104.
Barsheshet A, Leor J, Goldbourt U, Garty M, Schwartz R, Behar S, Luria D, Eldar M, Glikson M. Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am J Cardiol 2008;101:1303-1308.
Brodov Y, Sandach A, Boyko V, Matetzky S, Guetta V, Mandelzweig L, Behar S. Acute myocardial infarction preceded by potential triggering activities: angiographic and clinical characteristics. Int J Cardiol 2008;130:180-184.
Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, Gottlieb S, Ezra D, Lewis BS, Leor J. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J 2008;29:1029-1036.
Feinberg MS, Schwartz R, Behar S. Impact of metabolic syndrome in patients with acute coronary syndrome. Adv Cardiol 2008;45:114-126.
Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Am J Cardiol 2009;103:41-45.
Fefer P, Hod H, Hammerman H, Boyko V, Behar S, Matetzky S for the Acute Coronary Syndrome Israeli Survey. Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction. Am J Cardiol 2009;103:149-153.
Node K, Inoue T, Boyko V, Goldenberg I, Fisman EZ, Adler Y, Schwammenthal E, Matas Z, Behar S, Tenenbaum A. Long-term effects of Peroxisome Proliferator-Activated Receptor Ligand Bezafibrate on N-Terminal Pro-B Type Natriuretic Peptide in patients with advanced functional capacity impairment. Cardiovasc Diabetol 2009;8:1-5.
Goldenberg I, Boyko V, Tenenbaum A, Tanne D, Behar S. Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate. Arch Intern Med 2009;169:508-514.
Halkin A, Fourey D, Roth A, Boyko V, Behar S. Incidence and prognosis of non-Q-wave vs. Q-wave myocardial infarction following catheter-based reperfusion therapy. Q J Med 2009;102:401-406.
Garty M, Cohen E, Zuchenko A, Behar S, Boyko V, Iakobishvili Z, Mittelman M, Battler A, Shotan A, Gottlieb S, Caspi A, Hasdai D; Heart Failure Survey in ISrael (HFSIS) Investigators. Blood transfusion for acute decompensated heart failure – friend of foe? Am Heart J 2009;158:653-658.
Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology 2009;114:300-305.
Brodov Y, Behar S, Goldenberg I, Boyko V, Chouraqui P. Usefulness of combining serum uric acid and C-reative protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention (BIP) study. Am J Cardiol 2009;104,194-198.
Fefer P, Hod H, Hammerman H, Segev A, Beinart R, Boyko V, Behar S, Matetzky S. Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Am J Cardiol 2009;104:514-518.
Tanne D, Tenenbaum A, Boyko V, Benderly M, Fisman EZ, Matas Z, Adler Y, Behar S. Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic disease. Eur J Neurol 2009;16:1217-1223.
Hasin T, Hochadel M, Gitt AK, Behar S, Bueno H, Hasin Y. Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. Am J Cardiol 2009;103:772-778.
Goldenberg I, Subirana I, Boyko V, Vila J, Elosua R, Permanyer-Miralda G, Ferreira-Gonzalez I, Benderly M, Guetta V, Behar S, Marrugat J. Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome.  Real-world data from the European Public Health Outcome Research and Indicators Collection Project. Arch Intern Med 2010;170:888-895.
Barsheshet A, Shotan A, Cohen E, Garty M, Goldenberg I, Sandach A, Behar S, Zimlichman E, Lewis BS, Gottlieb S, for the HFSIS Steering Committee and Investigators. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Failure 2010;12:833-840.

 

 

 

 

 

 

 

Beinart R, Abu Sham’a R, Segev A, Hod H, Guetta V, Shechter M, Boyko V, Behar S, Matezky S. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome. Am Heart J 2010;159:118-124.
Sa’ar M, Behar S, Krakover R, Boyko V, Vered Z, Alex B. Characteristics and outcome of patients with acute coronary syndrome and normal or near-normal coronary angiography.  Coronary Art Dis 2010;21:212-216.
Iakobishvili Z, Porter A, Battler A, Behar S, Roth A, Atar S, Boylo V, Mager A, Hasddai D. Effect of narcotic treatment on outcomes of acute coronary syndrome. Am J Cardiol 2010;105:912-916.
Brodov Y, Behar S, Boyko V, Chouraqui P. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). Am J Cardiol 2010:106:1717-1720.
Rott D, Leibowitz D, Schwartz R, Weiss AT, Behar S, Hod H. Combination of the Killip and TIMI classifications for early risk stratification of patients with acute ST elevation myocardial infarction. Cardiology 2010;117:291-295.
Lubovich A, Hamood H, Behar S, Rosenschein U. Bypassing the Emergency Room to reduce door-to-door time and improve outcomes of patients with ST elevation myocardial infarction: The Acute Coronary Syndrome Israeli Survey Experience.  IMAJ 2011;13:216-219.
Shotan A, Blondheim DS, Gottlieb S, Kazatsker M, Frimerman A, Shochat M, Garty M, Boyko V, Behar S, Meisel SR for the Working Group on Intensive Cardiac Care, Israel Heart Society, and Acute Coronary Syndrome Israeli Survey Investigators. Comparison of outcome of recurrent versus first ST-segment elevation myocardial infarction (from National Israel Surveys 1998 to 2006). Am J Cardiol 2011;107:1730-1737.
Neuman Y, Pereg D, Boyko V, Behar S, Mosseri M. Primary angioplasty in patients following coronary artery bypass surgery: trends in application and outcome. Results from the acute coronary syndrome Israeli Survey (ACSIS) 2000-2008. Catheter Cardiovasc Inter. 2011;78:532-536. doi: 10.1002/ccd.23029. Epub 2011 Jul 25.
Iakobishvili Z, Cohen E, Garty M, Behar S, Shotan A, Sandach A, Gottlieb S, Mager A, Battler A, Hasdai D; Heart Failure Survey in Isarel (HFSIS) Investigators. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Acute Card Care 2011;13:76-80.
Lubovich A, Hamood H, Behar S, Rosenschein U. Bypassing the emergency room to reduce door-to-balloon time and improve outcomes of patients with ST elevation myocardial infarction: the Acute Coronary Syndrome Israeli Survey experience. Isr Med Assoc J 2011;13:216-219.
Greenberg G, Cohen E, Garty M, Iakobishvili Z, Sandach A, Behar S, Shotan A, Gottlieb S, Mager A, Battler A, Hasdai D. Outcomes of acute heart failure associated with acute coronary syndrome versus other causes. Acute Card Care 2011;13:87-92. Epub 2011 Apr 28.

 

`